Open AccessAnticoagulation in patients with atrial fibrillation and coronary artery disease
Author(s) -
Fahad Alkindi,
Ihsan Rafie
Publication year - 2020
Publication title -
heart views
Language(s) - English
Resource type - Journals
eISSN - 0976-5123
pISSN - 1995-705X
DOI - 10.4103/heartviews.heartviews_138_19
Subject(s) - medicine , antithrombotic , atrial fibrillation , coronary artery disease , percutaneous coronary intervention , cardiology , anticoagulant therapy , artery , intensive care medicine , myocardial infarction
The management of antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention for coronary artery disease remains a challenge in clinical practice. This group of patients has indications for both oral anticoagulation and antiplatelet therapy. Such combination will require careful considerations of both thromboembolic and bleeding risks. There have been several big trials looking at the rationale of treating those patients with an oral anticoagulant in combination with one (dual-therapy strategy) or two antiplatelet agents (triple-therapy strategy).